Clinical evaluation of 3.0-mm narrowdiameter implants: a retrospective study with up to 5 years of observation
- Author:
InKyung HWANG
1
;
Tae-Il KIM
;
Young-Dan CHO
Author Information
- Publication Type:Research Article
- From:Journal of Periodontal & Implant Science 2024;54(1):44-52
- CountryRepublic of Korea
- Language:EN
-
Abstract:
Purpose:This study aimed to evaluate the clinical outcomes of a single type of narrowdiameter implant (NDI) by investigating its survival rate and peri-implant marginal bone loss (MBL). In addition, variables possibly related to implant survival and MBL were investigated to identify potential risk factors.
Methods:The study was conducted as a retrospective study involving 49 patients who had received 3.0-mm diameter TSIII implants (Osstem Implant Co.) at Seoul National University Dental Hospital. In total, 64 implants were included, and dental records and radiographic data were collected from 2017 to 2022. Kaplan-Meier survival curves and a Cox proportional hazard model were used to estimate the implant survival rate and to investigate the effects of age, sex, jaw, implant location, implant length, the stage of surgery, guided bone regeneration, type of implant placement, and the surgeon’s proficiency (resident or professor) on implant survival. The MBL of the NDIs was measured, and the factors influencing MBL were evaluated.
Results:The mean observation period was 30.5 months (interquartile range, 26.75–45 months), and 6 out of 64 implants failed. The survival rate of the NDIs was 90.6%, and the multivariate Cox regression analysis showed that age was associated with implant failure (hazard ratio, 1.17; 95% confidence interval, 1.04–1.31, P=0.01). The mean MBL was 0.44±0.75 mm, and no factors showed statistically significant associations with greater MBL.
Conclusions:NDIs can be considered a primary alternative when standard-diameter implants are unsuitable. However, further studies are required to confirm their long-term stability.
